Search research articles
Contact Us
Filters
Showing results (51-60 of 136) with videos related to
Page
of 14
Sort By:
International Journal of Cancer
|
May 15, 1984
Calcium concentration defines two stages in transformation of lymphocytes by Epstein-Barr virus
D J Moss, S R Burrows, P G Parsons
International Journal of Cancer
|
August 26, 1998
p53 expression and risk factors for cutaneous melanoma: a case-control study
D C Whiteman, P G Parsons, A C Green
Biochemical Pharmacology
|
July 6, 1993
Inhibition of melanogenesis in human melanoma cells by novel analogues of the partial histamine (H2) agonist nordimaprit
G A Fechner, J J Jacobs, P G Parsons
The Journal of Pathology
|
November 1, 1994
Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin
K Saitoh, H Takahashi, N Sawada, et al.
Australian Veterinary Journal
|
September 19, 1998
Enterotoxaemia in goats in Australia
F A Uzal, W R Kelly, P G Parsons
Biochemical and Biophysical Research Communications
|
June 15, 1994
Dimaprit analogues inhibit tyrosinase via a disulphide breakdown product independently of the histamine H2 receptor
G A Fechner, J J Jacobs, P G Parsons
Photochemistry and Photobiology
|
June 26, 2001
Photosensitization of the sunscreen octyl p-dimethylaminobenzoate by UVA in human melanocytes but not in keratinocytes
C Xu, A Green, A Parisi, et al.
Virchows Archiv : an International Journal of Pathology
|
January 1, 1995
Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumours
H Takahashi, K Saitoh, H Kishi, et al.
The Medical Journal of Australia
|
May 13, 1998
The shady side of solar protection
P G Parsons, R Neale, P Wolski, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
October 1, 1991
A melanoma octamer binding protein is responsive to differentiating agents
R A Sturm, F Bisshop, H Takahashi, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 136) with videos related to
Sort By:
Page
of 14
International Journal of Cancer
|
May 15, 1984
Calcium concentration defines two stages in transformation of lymphocytes by Epstein-Barr virus
D J Moss, S R Burrows, P G Parsons
International Journal of Cancer
|
August 26, 1998
p53 expression and risk factors for cutaneous melanoma: a case-control study
D C Whiteman, P G Parsons, A C Green
Biochemical Pharmacology
|
July 6, 1993
Inhibition of melanogenesis in human melanoma cells by novel analogues of the partial histamine (H2) agonist nordimaprit
G A Fechner, J J Jacobs, P G Parsons
The Journal of Pathology
|
November 1, 1994
Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin
K Saitoh, H Takahashi, N Sawada, et al.
Australian Veterinary Journal
|
September 19, 1998
Enterotoxaemia in goats in Australia
F A Uzal, W R Kelly, P G Parsons
Biochemical and Biophysical Research Communications
|
June 15, 1994
Dimaprit analogues inhibit tyrosinase via a disulphide breakdown product independently of the histamine H2 receptor
G A Fechner, J J Jacobs, P G Parsons
Photochemistry and Photobiology
|
June 26, 2001
Photosensitization of the sunscreen octyl p-dimethylaminobenzoate by UVA in human melanocytes but not in keratinocytes
C Xu, A Green, A Parisi, et al.
Virchows Archiv : an International Journal of Pathology
|
January 1, 1995
Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumours
H Takahashi, K Saitoh, H Kishi, et al.
The Medical Journal of Australia
|
May 13, 1998
The shady side of solar protection
P G Parsons, R Neale, P Wolski, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
October 1, 1991
A melanoma octamer binding protein is responsive to differentiating agents
R A Sturm, F Bisshop, H Takahashi, et al.
Page
of 14